What to watch with ApoB and menopause?

ApoB (apolipoprotein B) is a direct measure of the number of atherogenic lipoprotein particles and is considered a more accurate risk marker than LDL cholesterol alone. During menopause, estrogen decline leads to increased LDL and ApoB levels, along with a shift toward smaller, denser LDL particles—a particularly atherogenic profile. Women should monitor ApoB, LDL, HDL, triglycerides, and lipoprotein(a) regularly during perimenopause and postmenopause. An elevated ApoB (>1.0 g/L) warrants lifestyle intervention (diet, exercise) and possibly pharmacotherapy (e.g., statins). Evidence comes from prospective cohort studies and post-hoc analyses of major lipid trials. Caveat: single measurements are not diagnostic; assessment should consider overall risk profile (age, blood pressure, smoking, diabetes). MyBody-X offers ApoB testing as part of its lipid panel, but without menopause-specific reference ranges. Medical interpretation is essential.